Cyclic cyanoenone derivatives as modulators of KEAP1
CYCLIC CYANOENONE DERIVATIVES AS MODULATORS OF KEAPI Abstract (I) The present invention relates to cyclic cyanoenone derivatives of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R2, R3, R4 and mare as defined herein. The present invention also relates to pharmaceutical compositions comprising the cyclic cyanoenone derivatives of Formula (I) and to their use in therapy..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 08. Feb. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ALTMAN MICHAEL [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-08, Last update posted on www.tib.eu: 2024-02-23, Last updated: 2024-03-01 |
|---|
| Patentnummer: |
AU2024200393 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA019264240 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA019264240 | ||
| 003 | DE-627 | ||
| 005 | 20240301101408.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA019264240 | ||
| 035 | |a (EPA)AU2024200393 | ||
| 035 | |a (EPA)71661743 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ALTMAN MICHAEL |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cyclic cyanoenone derivatives as modulators of KEAP1 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-08, Last update posted on www.tib.eu: 2024-02-23, Last updated: 2024-03-01 | ||
| 520 | |a CYCLIC CYANOENONE DERIVATIVES AS MODULATORS OF KEAPI Abstract (I) The present invention relates to cyclic cyanoenone derivatives of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R2, R3, R4 and mare as defined herein. The present invention also relates to pharmaceutical compositions comprising the cyclic cyanoenone derivatives of Formula (I) and to their use in therapy. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C07C: Acyclic or carbocyclic compounds (macromolecular compounds c08;production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CANDITO DAVID A |4 aut | |
| 700 | 0 | |a CHRISTIAN ALEC H |4 aut | |
| 700 | 0 | |a DI PIETRO ORNELLA |4 aut | |
| 700 | 0 | |a LU MIN |4 aut | |
| 700 | 0 | |a LIU PING |4 aut | |
| 700 | 0 | |a MANSOOR UMAR FARUK |4 aut | |
| 700 | 0 | |a MENNIE KATRINA MARIE |4 aut | |
| 700 | 0 | |a MUSACCHIO ANDREW J |4 aut | |
| 700 | 0 | |a PALANI ANANDAN |4 aut | |
| 700 | 0 | |a REUTERSHAN MICHAEL H |4 aut | |
| 700 | 0 | |a SHAW DAVID MATTHEW |4 aut | |
| 700 | 0 | |a ST-GALLAY STEPHEN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 08. Feb. |
| 773 | 1 | 8 | |g year:2024 |g day:08 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71661743/publication/AU2024200393A1?q=AU2024200393 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 08 |c 02 | ||